Literature DB >> 15521013

Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites.

E Sérée1, P-H Villard, J-M Pascussi, T Pineau, P Maurel, Q B Nguyen, F Fallone, P-M Martin, S Champion, B Lacarelle, J-F Savouret, Y Barra.   

Abstract

BACKGROUND AND AIMS: Cytochrome P450 1A1 catalyzes the degradation of endobiotics (estradiol, fatty acids, and so on) and the bioactivation of numerous environmental procarcinogens, such as arylamines and polycyclic aromatic hydrocarbons, that are found in food. Several peroxisome proliferators and arachidonic acid derivatives enhance cytochrome P450 1A1 activity, but the mechanisms involved remain unknown. The aim of this work was to study the role of peroxisome proliferator-activated receptors in cytochrome P450 1A1 gene induction.
METHODS: The role of peroxisome proliferator-activated receptor transcription factors in cytochrome P450 1A1 induction was assessed by means of enzymatic activities, quantitative real-time polymerase chain reaction, gene reporter assays, mutagenesis, and electrophoretic mobility shift assay.
RESULTS: We show that peroxisome proliferator-activated receptor-alpha agonists (WY-14643, bezafibrate, clofibrate, and phthalate) induce human cytochrome P450 1A1 gene expression, whereas 2,4-thiazolidinedione, a specific peroxisome proliferator-activated receptor-gamma agonist, represses it. The induction of cytochrome P450 1A1 transcripts by WY-14643 was associated with a marked increase of ethoxyresorufin O -deethylase activity (10-fold at 200 mumol/L). Transfection of peroxisome proliferator-activated receptor-alpha complementary DNA enhanced cytochrome P450 1A1 messenger RNA induction by WY-14643, although WY-14643 failed to activate xenobiotic responsive element sequences. Two peroxisome proliferator response element sites were located at positions -931/-919 and -531/-519 of the cytochrome P450 1A1 promoter. Their inactivation by directed mutagenesis suppressed the inductive effect of WY-14643 on cytochrome P450 1A1 promoter activation. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay experiments showed that the 2 cytochrome P450 1A1 peroxisome proliferator response element sites bind the peroxisome proliferator-activated receptor-alpha/retinoid X receptor-alpha heterodimer.
CONCLUSIONS: We describe here a new cytochrome P450 1A1 induction pathway involving peroxisome proliferator-activated receptor-alpha and 2 peroxisome proliferator response element sites, indicating that peroxisome proliferator-activated receptor-alpha ligands, which are common environmental compounds, may be involved in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521013     DOI: 10.1053/j.gastro.2004.08.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

1.  APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production.

Authors:  Feng-Wei Wang; Chen-Hui Cao; Kai Han; Yong-Xiang Zhao; Mu-Yan Cai; Zhi-Cheng Xiang; Jia-Xing Zhang; Jie-Wei Chen; Li-Ping Zhong; Yong Huang; Su-Fang Zhou; Xiao-Han Jin; Xin-Yuan Guan; Rui-Hua Xu; Dan Xie
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

2.  Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.

Authors:  Xia Yang; Bin Zhang; Cliona Molony; Eugene Chudin; Ke Hao; Jun Zhu; Andrea Gaedigk; Christine Suver; Hua Zhong; J Steven Leeder; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger G Ulrich; J Greg Slatter; Eric E Schadt; Andrew Kasarskis; Pek Yee Lum
Journal:  Genome Res       Date:  2010-06-10       Impact factor: 9.043

Review 3.  The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells.

Authors:  Eszter Baricza; Viola Tamási; Nikolett Marton; Edit I Buzás; György Nagy
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

4.  Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1.

Authors:  Catherine Z Chen; Krzysztof Sobczak; Jason Hoskins; Noel Southall; Juan J Marugan; Wei Zheng; Charles A Thornton; Christopher P Austin
Journal:  Anal Bioanal Chem       Date:  2012-01-05       Impact factor: 4.142

5.  Teleost fish (Solea solea): a novel model for ecotoxicological assay of contaminated sediments.

Authors:  C Ribecco; G Hardiman; R Sášik; S Vittori; O Carnevali
Journal:  Aquat Toxicol       Date:  2011-12-13       Impact factor: 4.964

6.  CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver.

Authors:  Ngome L Makia; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2015-10-14       Impact factor: 4.436

Review 7.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

8.  Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.

Authors:  Manhai Long; Mandana Ghisari; Eva Cecilie Bonefeld-Jørgensen
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-29       Impact factor: 4.223

9.  The Role of PPARα Activation in Liver and Muscle.

Authors:  Lena Burri; G Hege Thoresen; Rolf K Berge
Journal:  PPAR Res       Date:  2010-08-18       Impact factor: 4.964

10.  Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.

Authors:  Maryam Rakhshandehroo; Guido Hooiveld; Michael Müller; Sander Kersten
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.